SECOND EXTENSION - GRANTED
granted
on 14 Aug 2024
Last Applicant/ Owned by
1350 S. LOOP ROAD
ALAMEDA
CA
94502
Serial Number
97523882 filed on 28th Jul 2022
Registration Number
N/A
Correspondent Address
Scott B. Dunbar
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
O VIVANI
Nanoporous membranes used in drug delivery devices for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy; miniature long-term drug implants utilizing proprietary implantable drug delivery technology; nan Read More
Classification Information
Class [010]
Medical Instrument Products
Nanoporous membranes used in drug delivery devices for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy; miniature long-term drug implants utilizing proprietary implantable drug delivery technology; nanoporous membranes used for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant where the drug reservoir dictates the duration of therapy delivered from the drug implant for treatment of metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy, and other diseases treated with small drug molecules; Electrotherapy medical devices for electrical nerve stimulation and recording, namely, neurostimulation devices, stimulating and recording electrode implants, visual prostheses and visual cortical implants; Cortical electrodes integrally attached to implantable cortical stimulators and other systems, namely, electrodes, stimulators, headpieces, and wearable video processors for the treatment of blindness; Surgical apparatus and instruments for the treatment of blindness; Medical apparatus and instruments for use in surgery for the treatment of blindness; Medical devices for the treatment of blindness
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Implantable drug delivery devices having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy; Implantable drug delivery devices having a drug reservoir and a nanoporous membrane sold preloaded with a therapeutic agent, namely, an injectable device for time release of the therapeutic agent for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Nanoporous membranes used in drug delivery devices for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; Nanoporous membranes used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant where the drug reservoir dictates the duration of therapy delivered from the drug implant
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97523882
Mark Type
No Service/Collective Mark
Attorney Docket Number
No S-17
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
26.19.01 -
Spheres
Legal History
| Status Date | Action Taken |
|---|---|
| 15th Aug 2024 | SOU EXTENSION 2 FILED |
| 15th Aug 2024 | SOU EXTENSION 2 GRANTED |
| 15th Aug 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 14th Aug 2024 | SOU TEAS EXTENSION RECEIVED |
| 21st Feb 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 09th Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 07th Feb 2024 | SOU EXTENSION 1 FILED |
| 07th Feb 2024 | SOU EXTENSION 1 GRANTED |
| 07th Feb 2024 | SOU TEAS EXTENSION RECEIVED |
| 15th Aug 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |